Table 1.
CAD status | Author; year | Study design | N | Follow-up | Control group | Intervention group | Symptomatic outcomes (e.g. 6MWT, QoL) | LVEF | Prognostic outcomes (e.g. hospitalizations) | |
---|---|---|---|---|---|---|---|---|---|---|
Stable CAD | The difference between baseline and follow-up: intervention vs. control group | |||||||||
or recent ACS/revasc | Anderson et al., 2016 | Meta-analysis | 14 486 | >6mo | Usual care | Exe int. | QoL: Improved |
Hospitalizations: −28% CVD mortality: −26% Total mortality: No difference |
||
or PCI | Gomes-Neto et al., 2017 | Meta-analysis | 609 | Exe int | HIIT int | VO2 peak: +1.3 ml/kg/min QoL: No difference |
||||
Hambrecht et al., 2004 | RCT | 101 | 12mo | PCI | Exe int. (no PCI) | VO2peak: +3.6 vs. +0.5 ml/kg/min | Ischemia-free survival: +26% Total mortality: No difference |
|||
Maddison et al., 2015 | RCT | 171 | 6mo | Usual care | PA int. | Daily walking time: +63 vs. −56 min | ||||
Oerkild et al., 2012 | RCT | 40 | 12mo | Usual care | Exe int. | 6MWT at 3mo: +12% vs. +3% QoL: No difference |
||||
or recent ACS/revasc | Rawstorn et al., 2016 | Meta-analysis | 1189 | 3mo | Usual care Exe int |
Telehealth Exe int | PA:Improved VO2 peak: No difference |
|||
Post-ACS | ||||||||||
Briffa et al., 2005 | RCT | 113 | 12mo | Usual care | Exe int. | QoL: Improved |
||||
and PCI or CABG |
Frederix et al., 2015 | RCT | 80 | 18 week | Usual care | PA int. | VO2peak: +4 vs. +1 ml/kg/min | Hospitalizations: -53% | ||
La Rovere et al., 2002 | RCT | 95 | 10y | Usual care | Exe int. | CVD mortality: 12% vs. 26% |
||||
Lawler et al., 2011 | RCT | 6111 | 3mo – 5y | Usual care | Exe int. | Mortality: −26% CVD mortality: −40% |
||||
Marchionni et al., 2003 | RCT | 270 | 14mo | Usual care | Exe int. In 1. Hospital or 2. Home | QoL: Improved in older patients Total work capacity: Improved (both in hospital and home –based) |
||||
Reid et al., 2012 | RCT | 223 | 12mo | Usual care | PA int. | Daily step count: 7392 vs. 6750 |
||||
Xu et al., 2016 | RCT | 52 | 4 week | Usual care | Exe int. | LVEF: +4.1% vs. −1.7% | ||||
or PCI | Yu et al., 2004 | RCT | 269 | 24mo | Usual care | Exe int. | QoL: Improved |
Re-PCI: 13% vs. 26% Total mortality: No difference |
||
Wang et al., 2012 | RCT | 160 | 6mo | Usual care | Exe int. | QoL: Improved Depression: No difference |
||||
West et al., 2012 | RCT | 1813 | 24mo | Usual care | Exe int. | No difference in any outcome above. | ||||
Post-PCI/CABG | ||||||||||
PCI | Belardinelli et al., 2001 | RCT | 118 | 33mo | Usual care | Exe int. | VO2 peak: +5 vs. −1 ml/kg/min QoL: Improved |
Hospitalizations: −60% Restenosis: No difference |
||
CABG | Moholdt et al., 2009 | RCT | 59 | 6mo | Exe int. | Aerobic interval int. | VO2peak at 6mo: 18.8% vs. 12.6% |
|||
PCI | Munk et al., 2009 | RCT | 40 | 6mo | Usual care | Exe int. | VO2peak: 16.8% vs. 7.8% |
Late luminal loss: 0.1 vs. 0.4 mm |
||
CABG | Mutwalli et al., 2012 | RCT | 49 | 6mo | Usual care | Exe int. | QoL: Improved |
|||
PCI | Higgins et al., 2001 | RCT | 99 | 12mo | Usual care | Exe int. | Functional capability: Improved Sick leave: Shorter |
Abbreviations: ACS: Acute coronary syndrome; CABG: Coronary artery bypass grafting; CAD: Coronary artery disease; CVD: Cardiovascular disease; Exe int: Interventions based on structured or supervised exercise sessions; HIIT: High-intensity interval training; LVEF: Left ventricular ejection fraction; N: Number of study participants; PA: Physical activity; PA Int: Intervention based on patient’s daily PA goals of which fulfillment is monitored; PCI: Percutaneous coronary intervention; QoL: Quality of life; RCT: Randomized controlled trial; Rehab.: Rehabilitation; Rehosp.: Rehospitalizations; Revasc: Revascularization; Review: Review of RCTs; VO2peak: Maximal oxygen consumption; 6MWT: 6-min walk test; +: Increased/Improved; -: Decreased.